CC
Comprehensive Care (Poster)
Thursday, May 29, 2014: 7:00 PM-8:30 PM
Trinity Exhibit Hall
Understanding Drivers of Employment Change in a Multiple Sclerosis (MS) Population
Karin Coyne, PhD, MPH, Evidera;
Todd Wandstrat, BS Pharm, RPh, PharmD, Genzyme;
Amanda Landrian, BS, Evidera;
Audra Boscoe, PhD, Genzyme
The Evolving Knowledge of Multiple Sclerosis in LATIN American Countries in the 20th Century
José A Cabrera Gómez, MD, PhD, International Center of Neurological Restoration;
Alina González-Quevedo, MD, PhD, Institute of Neurology and Neurosurgery;
María L Rodríguez-Cordero, BD, International Center of Neurological Restoration;
Martha Cristofol-Corominas, Prof, International Center of Neurological Restoration;
Anelis Y Cabrera-Núñez, MD, Medical School “Raúl Dorticos Torrado”;
John F Kurtzke, MD, Georgetown University
To What Degree Are People with Multiple Sclerosis in Greater Manchester Satisfied with the Services Offered to Them
Karen Vernon, BSc (hons). RGN., Salford Royal NHS Trust;
David Rog, MD, MRCP (UK), Salford Royal NHS Trust;
Fran Jackson, SRN, Salford Royal NHS Trust;
Azeez Pervez, BSc Hons, Salford Royal NHS Trust;
Paul Talbot, MB ChB MD FRCP, Salford Royal NHS Trust
Shared Decision Making in Multiple Sclerosis: Option Grid (OG) Point of Care Engagement Tools (POCETs) for Dmt Treatment (Work in Progress)
Karen Winn, RN, MSN, DNP, MGH Institute of Health Professions, Boston, MA;
Brant J. Oliver, PhD, NP, MSN, MPH, MSCN, MGH Institute of Health Professions, Boston, MA
Advanced Practice Clinicians' Perspective: Management of Patients on Oral Disease- Modifying Therapy for Multiple Sclerosis
Mary Filipi, PhD, APRN, MS Center of Nebraska;
John Kramer, PA-C, Wheaton Franciscan Regional MS Center;
Mary Margaret Hillstrand, ANP, DNP, Mary Margaret Hillstrand Neurology Practice;
Teresa Frohman, MPAS, PA-C, University of Texas Southwestern;
Megan Weigel, DNP, ARNP-C, MSCN, Baptist Neurology;
Akanksha Mittal, PhD, Genzyme, a Sanofi company;
Colleen Miller, DNS, Genzyme, a Sanofi company
Clinical Characteristics Associated with High Cost MS Patients Using Claims and Medical Records Data, Stratified By Cost
Debra F. Eisenberg, MS, PhD, HealthCore, Inc.;
Prakash Navaratnam, Rph, MPH, PhD, DataMed Solutions LLC.;
Xuehua Ke, MA, HealthCore, Inc.;
Nadia Ramey, MPH, HealthCore, Inc.;
Howard Friedman, PhD, DataMed Solutions LLC.;
Neetu Agashivala, MS, Novartis Pharmaceutical Corporation;
Rahul Sasane, PhD, Novartis Pharmaceutical Corporation;
Timothy Vollmer, MD, University of Colorado School of Medicine, RMMSC at Anschutz
Patterns in MS Needs Over Time
Robert Rapp, MPA, Multiple Sclerosis Association of America;
Donna Van Alst, PhD, Rutgers, The State University of New Jersey;
Shrivridhi Skukla, PhD (candidate), Rutgers, The State University of New Jersey
Betaconnect Autoinjector: Patient/Caregiver Satisfaction
Samuel F. Hunter, MD, PhD, Novel Pharmaceutics Institute;
Hans J Jensen, BSc, MBA, Bang & Olufsen Medicom;
Paul E Fabricius, BSc, EE, Bang & Olufsen Medicom;
Mark Rametta, DO, Bayer HealthCare Pharmaceuticals
